Business Description
Axcella Health Inc
NAICS : 325412
SIC : 2834
Description
Axcella Health Inc a biotechnology company focused on treating complex diseases and improve health using endogenous metabolic modulator, or EMM, compositions. Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios to simultaneously impact multiple biological pathways. The company's pipeline includes lead therapeutic candidates, AXA1665 for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125 for non-alcoholic steatohepatitis.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.39 | |||||
| Equity-to-Asset | -0.24 | |||||
| Debt-to-Equity | -0.62 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 24.4 | |||||
| 3-Year EPS without NRI Growth Rate | 27 | |||||
| 3-Year FCF Growth Rate | 25.2 | |||||
| 3-Year Book Growth Rate | -72.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 5.08 | |||||
| 9-Day RSI | 14.71 | |||||
| 14-Day RSI | 20.64 | |||||
| 6-1 Month Momentum % | -83.27 | |||||
| 12-1 Month Momentum % | -87.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | |||||
| Quick Ratio | 0.8 | |||||
| Cash Ratio | 0.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -47 | |||||
| Shareholder Yield % | -816.12 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -5506.97 | |||||
| ROA % | -198.09 | |||||
| ROIC % | -556.45 | |||||
| 3-Year ROIIC % | -1915.21 | |||||
| ROC (Joel Greenblatt) % | -3029.41 | |||||
| ROCE % | -519.97 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | 0.14 | |||||
| EV-to-EBITDA | 0.14 | |||||
| EV-to-FCF | 0.15 | |||||
| Earnings Yield (Greenblatt) % | 714.29 | |||||
| FCF Yield % | -3641.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AXLA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Axcella Health Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -19.25 | ||
| Beta | 0 | ||
| Volatility % | 192.01 | ||
| 14-Day RSI | 20.64 | ||
| 14-Day ATR ($) | 0.270826 | ||
| 20-Day SMA ($) | 0.744439 | ||
| 12-1 Month Momentum % | -87.89 | ||
| 52-Week Range ($) | 0.34 - 41.25 | ||
| Shares Outstanding (Mil) | 2.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Axcella Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Axcella Health Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Axcella Health Inc Frequently Asked Questions
What is Axcella Health Inc(AXLA)'s stock price today?
The current price of AXLA is $0.40. The 52 week high of AXLA is $41.25 and 52 week low is $0.34.
When is next earnings date of Axcella Health Inc(AXLA)?
The next earnings date of Axcella Health Inc(AXLA) is 2025-01-05 Est..
Does Axcella Health Inc(AXLA) pay dividends? If so, how much?
Axcella Health Inc(AXLA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers